Susceptibility to ankylosing spondylitis is independent of the Bw4 and Bw6 epitopes of HLA-B27 alleles

Tissue Antigens

Volumn 53, Issue 3, 1999, Pages 237-243

  Armas, J B ^a   Gonzalez, S ^b   Martinez Borra, J ^b   Laranjeira, F ^a   Ribeiro, E ^a   Correia, J ^a   Ferreira, M L ^a   Toste, M ^a   Lopez Vazquez A ^b   López Larrea, Carlos ^b  

^a Hospital Santo Espirito de Angra do Heroesmo   (Portugal)

^b HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

Author keywords

Ankylosing spondylitis; B*2708 allele; B27 alleles; Bw4 Bw6 epitopes; HLA and disease association

Indexed keywords

EPITOPE; HLA B27 ANTIGEN;

ALLELE; ANKYLOSING SPONDYLITIS; ARTICLE; ATLANTIC ISLANDS; CAUCASIAN; CLINICAL ARTICLE; DISEASE PREDISPOSITION; ETHNIC GROUP; FEMALE; GENETIC POLYMORPHISM; HUMAN; MALE; NORMAL HUMAN; PATHOGENESIS; POLYMERASE CHAIN REACTION; POPULATION; POPULATION GENETICS; PRIORITY JOURNAL; SEQUENCE ANALYSIS; T LYMPHOCYTE; UNITED KINGDOM;

AFRICAN CONTINENTAL ANCESTRY GROUP; AZORES; DISEASE SUSCEPTIBILITY; EPITOPE MAPPING; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HLA-B ANTIGENS; HLA-B27 ANTIGEN; HUMANS; PEDIGREE; SPONDYLITIS, ANKYLOSING;

EID: 0033024247     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0039.1999.530303.x     Document Type: Article

References (31)

1. López de Castro JA. The pathogenetic role of HLA-B27 in chronic arthritis. Curr Opin Immunol 1998: 10: 59-66.
2. González-Roces S, Alvarez MV, Gonzalez S et al. HLA-B27 polymorphism and worldwide susceptibility to ankylosing spondylitis. Tissue Antigens 1997: 49: 116-23.
3. Brown MA, Pile KD, Kennedy LG et al. HLA class I associations of ankylosing spondylitis in the white population in the United Kingdom. Ann Rheum Dis 1996: 55: 268-70.
4. Taurog JD. HLA-B27 subtypes, disease susceptibility, and peptide binding specificity. In: Calin A, Taurog D, eds. The spondylarthritides. Oxford: Oxford University Press, 1998: 267-73.
5. López-Larrea C, González S, Martinez-Borra J. The role of HLA-B27 polymorphism and molecular mimicry in spondylarthropathy. Mol Med Today 1998: in press.
6. López-Larrea C, Sujirachato K, Mehra NK et al. HLA-B27 subtypes in Asian patients with ankylosing spondylitis. Evidence for new associations. Tissue Antigens 1995: 45: 169-76.
7. D'Amato M, Fiorillo MT, Carcassi C et al. Relevance of residue 116 of HLA-B27 in determining susceptibility to ankylosing spondylitis. Eur J Immunol 1995: 25: 3199-201.
8. Hildebrand W, Domena J, Shen SY et al. The HLA-B7Qui antigen is encoded by a new subtype of HLA-B27 (B*2708). Tissue Antigens 1994: 44: 47-51.
9. Balas A, Santos S, Garcia-Sanchez F, Lillo R, Merino JL, Vicario JL. Complete coding sequence of HLA-B*2712: a serologic B27-negative antigen associated to Bw6, Tissue Antigens 1998: 51: 394-97.
10. Fiorillo MT, Meadows L, D'Amato M et al. Susceptibility to ankylosing spondylitis correlates with the C-Terminal residue of peptides presented by various HLA-B27 subtypes. Eur J Immunol 1997: 27: 368-73.
11. Garcia F, Marina A, López de Castro JA. Lack of carboxyl-terminal tyrosine distinguishes the B*2706-bound peptide repertoire from those of B*2704 and other HLA-B27 subtypes associated with ankylosing spondylitis, Tissue Antigens 1997: 49: 215-21.
12. Arnaiz-Villena A, Martínez-Laso J, Gómez-Casado E et al. Relatedness among Basques, Portuguese, Spaniards, and Algerians studied by HLA allelic frequencies and haplotypes. Immunogenetics 1997: 47: 37-43.
13. van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984: 27: 361-8.
14. Braun J, Bollow M, Eggens U. Use of dynamic magnetic resonance imaging with fast imaging in the detection of early and advanced sacroilitis in spondylarthropathy patients. Arthritis Rheum 1994: 37: 1039-45.
15. Miller SA, Dikes DED, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988: 16: 1215.
16. López-Larrea C, González-Roces S, Alvarez V. HLA-B27 DNA typing reference protocol. In: Charron D, ed. HLA genetic diversity of HLA-Functional and medical implications. Paris: EDK, 1997: 550-7.
17. López-Larrea C, González-Roces S, Peña M et al. Characterization of B27 haplotypes by oligotyping and genomic sequencing in the Mexican mestizo population with ankylosing spondylitis. Hum Immunol 1995: 43: 174-80.
18. van der Linden SM, Valkenberg HA, de Jongh B, Cats A. The risk of developing ankylosing spondylitis: a comparison of relatives of spondylitis patients with the general population. Arthritis Rheum 1984: 27: 241-9.
19. Brown MA, Kennedy LG, MacGregor AJ et al. Susceptibility to ankylosing spondylitis in twins. The role of genes, HLA, and the environment. Arthritis Rheum 1997: 40: 1823-8.
20. Brown MA, Pile KD, Kennedy LG et al. A genome-wide screen for susceptibility loci in ankylosing spondylitis, Arthritis Rheum 1998: 41: 588-95.
21. Höhler T, Schäper T, Schneider PM, Meyer zum Büschenfeld KH, Märker-Hermann E. Association of different tumor necrosis factor α promoter allele frequencies with ankylosing spondylitis in HLA-B27 individuals. Arthritis Rheum 1998: 41: 1489-92.
22. Arnett KL, Huang W, Valiante NM, Barber LD, Parham P. The Bw4/Bw6 difference between HLA-B*0802 and HLA-B*0801 changes the peptides endogenously bound and the stimulation of alloreactive T cells. Immunogenetics 1998: 48: 56-61.
23. Tieng V, Dulphy N, Boisgéraukt F, Tamouza R, Charron D, Toubert A. HLA-B*2707 peptide motif: Tyr C-terminal anchor is not shared by all disease associated subtypes. Immunogenetics 1997: 47: 103-5.
24. Gumperz JE, Barber LD, Valiante NM et al. Conserved and variable residues within the Bw4 motif of HLA-B make separable contributions to recognition by the NKB1 killer cell-inhibitory receptor. J Immunol 1997: 158: 5237-41.
25. Clayberger C, Rosen M, Parham P, Krensky AM. Recognition of an HLA public determinant (Bw4) by human allogeneic cytotoxic T lymphocytes. J Immunol 1990: 144: 4172-6.
26. López-Larrea C, Arnaiz-Villena A. The "public" determinants HLA-Bw4/Bw6 do not generate cytotoxic T lymphocytes (CTLs) Cellular Immunology 1989: 123: 441-4.
27. Hill A, Elvin J, Willis AC et al. Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature 1992: 360: 434-99.
28. Breur-Vriesendorp BS, Dekker-Saeys AJ, Ivanyi P. Distribution of HLA-B27 subtypes in patients with ankylosing spondylitis: the disease is associated with a common determinant of the various B27 molecules. Ann Rheum Dis 1987: 46: 353-6.
29. McLean I. HLA-B27 subtypes: implications for the spondyloarthropathies. Ann Rheum Dis 1992: 51: 929-31.
30. Nasution AR, Mardjuadi A, Kunmartini S et al. B27 subtypes and their association with ankylosing spondylitis. Abstract (no. 176) of the 16th European Workshop for Rheumatology Research, 1996.
31. Khan MA. Spondyloarthropathies - spondyloarthropathies. Curr Opin Rheumatol 1996: 8: 267-8.